81 FR 57932 - Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 81, Issue 164 (August 24, 2016)

Page Range		57932-57932
FR Document		2016-20241

Federal Register, Volume 81 Issue 164 (Wednesday, August 24, 2016)

[Federal Register Volume 81, Number 164 (Wednesday, August 24, 2016)]
[Notices]
[Page 57932]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20241]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Chattem 
Chemicals

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before October 24, 2016.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    The Attorney General has delegated her authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, dispensers, importers, and exporters of controlled 
substances (other than final orders in connection with suspension, 
denial, or revocation of registration) has been redelegated to the 
Deputy Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR 
part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
27, 2016, Chattem Chemicals, 3801 St. Elmo Avenue, Chattanooga, 
Tennessee 37409 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
4-Methoxyamphetamine (7411)................  I
Dihydromorphine (9145).....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Lisdexamfetamine (1205)....................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Meperidine intermediate-A (9232)...........  II
Meperidine intermediate-B (9233)...........  II
Meperidine intermediate-C (9234)...........  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Opium, powdered (9639).....................  II
Opium, granulated (9640)...................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution and sale to its customers.

Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-20241 Filed 8-23-16; 8:45 am]
 BILLING CODE 4410-09-P

57932 Federal Register / Vol. 81, No. 164 / Wednesday, August 24, 2016 / Notices

investigation are or will be available for 210 of the Commission’s Rules of Controlled substance Schedule
inspection during official business Practice and Procedure, 19 CFR part
hours (8:45 a.m. to 5:15 p.m.) in the 210. Dihydromorphine (9145) ............... I
Office of the Secretary, U.S. Amphetamine (1100) .................... II
By order of the Commission.
International Trade Commission, 500 E Methamphetamine (1105) ............ II
Issued: August 18, 2016. Lisdexamfetamine (1205) ............. II
Street SW., Washington, DC 20436, Lisa R. Barton, Methylphenidate (1724) ................ II
telephone (202) 205–2000. General Secretary to the Commission. Pentobarbital (2270) ..................... II
information concerning the Commission Codeine (9050) ............................. II
[FR Doc. 2016–20200 Filed 8–23–16; 8:45 am]
may also be obtained by accessing its Dihydrocodeine (9120) ................. II
BILLING CODE 7020–02–P
Internet server at https://www.usitc.gov. Oxycodone (9143) ........................ II
The public record for this investigation Hydromorphone (9150) ................ II
may be viewed on the Commission’s Hydrocodone (9193) ..................... II
electronic docket (EDIS) at https:// DEPARTMENT OF JUSTICE Meperidine (9230) ........................ II
edis.usitc.gov. Hearing-impaired Meperidine intermediate–A (9232) II
Drug Enforcement Administration Meperidine intermediate–B (9233) II
persons are advised that information on Meperidine intermediate–C (9234) II
this matter can be obtained by [Docket No. DEA–392] Methadone (9250) ........................ II
contacting the Commission’s TDD Methadone intermediate (9254) ... II
terminal on (202) 205–1810. Bulk Manufacturer of Controlled Morphine (9300) ........................... II
Substances Application: Chattem Oripavine (9330) ........................... II
SUPPLEMENTARY INFORMATION: The
Chemicals Thebaine (9333) ........................... II
Commission instituted this investigation
on June 24, 2016, based on a complaint Opium tincture (9630) .................. II
ACTION: Notice of application. Opium, powdered (9639) ............. II
filed by Intex Recreation Corp. of Long Opium, granulated (9640) ............ II
Beach, California; and Intex Marketing DATES: Registered bulk manufacturers of Oxymorphone (9652) ................... II
Ltd. of Tortola, British Virgin Islands the affected basic classes, and Noroxymorphone (9668) .............. II
(together, ‘‘Intex’’). 81 FR 41346–47. The applicants therefore, may file written Alfentanil (9737) ........................... II
complaint alleges that respondents comments on or objections to the Remifentanil (9739) ...................... II
Bestway (USA), Inc., of Phoenix, issuance of the proposed registration in Sufentanil (9740) .......................... II
Arizona; Bestway Global Holdings, Inc. accordance with 21 CFR 1301.33(a) on Tapentadol (9780) ........................ II
of Shanghai, China; Bestway (Hong Fentanyl (9801) ............................ II
or before October 24, 2016.
Kong) International Ltd. of Hong Kong; ADDRESSES: Written comments should
Bestway Inflatables & Materials The company plans to manufacture
be sent to: Drug Enforcement the listed controlled substances in bulk
Corporation of Shanghai, China; and Administration, Attention: DEA Federal
Bestway (Nantong) Recreation Corp. of for distribution and sale to its
Register Representative/ODW, 8701 customers.
Nantong, China (together, ‘‘Bestway’’), Morrissette Drive, Springfield, Virginia
are in violation of section 337 of the 22152. Louis J. Milione,
Tariff Act of 1930, as amended, 19 Deputy Assistant Administrator.
U.S.C. 1337, by reason of infringement SUPPLEMENTARY INFORMATION:
The Attorney General has delegated [FR Doc. 2016–20241 Filed 8–23–16; 8:45 am]
of certain claims of U.S. Patent Nos.
8,562,773 and 9,156,203. Id. The Office her authority under the Controlled BILLING CODE 4410–09–P

of Unfair Import Investigations (‘‘OUII’’) Substances Act to the Administrator of
is a party to the investigation. Id. at the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to DEPARTMENT OF JUSTICE
41347.
On July 14, 2016, Bestway filed a exercise all necessary functions with Drug Enforcement Administration
motion to terminate the investigation respect to the promulgation and
implementation of 21 CFR part 1301, [Docket No. DEA–392]
based upon a consent order stipulation
and proposed consent order. That same incident to the registration of
manufacturers, distributors, dispensers, Importer of Controlled Substances
day, OUII filed a response arguing that Application: Noramco, Inc.
the motion should be granted because it importers, and exporters of controlled
complies with the Commission Rules for substances (other than final orders in ACTION: Notice of application.
consent orders and termination serves connection with suspension, denial, or
the public interest. Intex did not revocation of registration) has been DATES: Registered bulk manufacturers of
respond to the motion. redelegated to the Deputy Assistant the affected basic classes, and
On July 25, 2016, the ALJ granted the Administrator of the DEA Office of applicants therefore, may file written
motion in the subject ID. She found that Diversion Control (‘‘Deputy Assistant comments on or objections to the
the motion for termination by consent Administrator’’) pursuant to section 7 of issuance of the proposed registration in
order stipulation complies with the 28 CFR part 0, appendix to subpart R. accordance with 21 CFR 1301.34(a) on
In accordance with 21 CFR or before September 23, 2016. Such
requirements of Commission Rule
1301.33(a), this is notice that on July 27, persons may also file a written request
210.21(c) and is in the public interest.
2016, Chattem Chemicals, 3801 St. Elmo for a hearing on the application
No petitions for review of the ID were
Avenue, Chattanooga, Tennessee 37409 pursuant to 21 CFR 1301.43 on or before
received.
applied to be registered as a bulk September 23, 2016.
The Commission has determined not
mstockstill on DSK3G9T082PROD with NOTICES

manufacturer of the following basic ADDRESSES: Written comments should
to review the subject ID and to issue a
classes of controlled substances: be sent to: Drug Enforcement
consent order. The investigation is
terminated in its entirety. Administration, Attention: DEA Federal
Controlled substance Schedule
The authority for the Commission’s Register Representative/ODW, 8701
determination is contained in section Gamma Hydroxybutyric Acid I Morrissette Drive, Springfield, Virginia
337 of the Tariff Act of 1930, as (2010). 22152. All requests for hearing must be
amended, 19 U.S.C. 1337, and in Part 4-Methoxyamphetamine (7411) ... I sent to: Drug Enforcement

VerDate Sep<11>2014 20:16 Aug 23, 2016 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\24AUN1.SGM 24AUN1

Document Created: 2016-08-24 03:02:14
Document Modified: 2016-08-24 03:02:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of application.
Dates		Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 24, 2016.
FR Citation		81 FR 57932

81 FR 57932 - Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 81, Issue 164 (August 24, 2016)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration